• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Allianz backs AV8 Ventures’ second fund focused on AI technologies

September 9, 2021 by David Barret Leave a Comment

AV8 Ventures unveiled its AV8 Ventures II fund with $180 million from Allianz Group, an insurance and asset management giant, aimed at supporting entrepreneurs developing artificial intelligence-driven technologies in the areas of health, mobility, enterprise and deep tech.

Since the Palo Alto venture firm’s launch in 2018, it has invested in 20 seed-stage companies, with another four in the pipeline. Its first fund was also $180 million and backed by Allianz, George Ugras, managing director at AV8, told TechCrunch. The new fund will also invest in seed stage and some Series A and will aim to go into 25 companies.

“The idea is to operate as a financial VC with the support of the world’ largest insurance company and asset manager behind us,” Ugras said.

Some of the technologies the firm is excited about include how chronic diseases are managed. Ugras believes the lack of access to swaths of data and alignment of interest around the table are prohibiting many of the right solutions from bubbling up. In enterprise, AV8 is looking at management around cyberattacks, predicting vulnerabilities and the impact they have on enterprises, so that companies can be proactive in securing their vulnerabilities versus reactive.

Meanwhile, the driver for the second fund was to ensure continuity in deal activity. AV8 “is seeing so many deals right now,” and the competition to get into a VC deal makes it difficult to project how fast a fund will be able to deploy the capital. Even if a firm gets excited and issues terms sheets, there is always uncertainty, he added.

With venture capital being abundant these days, Ugras noted that the velocity is the fastest he has seen in 22 years. The competitiveness in the market is such that if a startup has a decent team, there is no issue raising capital. However, on the investor side, they have to do things better than ever.

“In terms of the key diligence, you need domain expertise to be very clear on how you can add value and key execution milestones going forward,” he added. “Healthcare and insurance more so than others because the business models are complicated. If you have the startups educating you on the front end, it is going to be difficult for the fund.”

To guard against data loss and misuse, the cybersecurity conversation must evolve

 

Source Link Allianz backs AV8 Ventures’ second fund focused on AI technologies

David Barret
David Barret

Related posts:

  1. El Salvador’s world-first adoption of bitcoin hits snags
  2. IMF says crucial Chad gets debt treatment deal with private creditors
  3. Speech recognition works for kids, and it’s about time
  4. Guinea opposition leader says he’s open to participate in transition following coup

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • Should We Sleep Outside? Turns Out There Are Some Benefits
  • A US Federal Committee Is Meeting To Discuss Vaccines – Here’s What You Should Know
  • Neanderthal Noises, Dome-Headed Dinosaurs, And Mystery Larvae
  • Over Half Of Migrating Wildebeests Are Seemingly “Missing” In Latest Survey
  • Meet The Chewbacca Coral, A Ridiculously Fluffy New Species Discovered In The Deep Sea
  • Why Are School Buses Painted Yellow In The US?
  • What Are The Symptoms Of The “Stratus” COVID-19 Subvariant That’s Hitting The USA?
  • Intrepid Jaguar Swims Over 1 Kilometer, Smashing Previous Distance Record By More Than 6 Times
  • Breakthrough 3D Bioprinted Mini Placentas May Help Solve “One Of Medicine’s Great Mysteries”
  • Meet The “Grue Jay”: A Bizarre Rare Bird Spotted In Texas Is A Unique Hybrid Of Two Different Species
  • 21 Grams Experiment: In 1907, A Doctor Tried To Prove The Existence Of The Soul Using Weighing Scales
  • The World’s Oldest Known Cake Is Over 4,000 Years Old, And It Sounds Pretty Delicious
  • An Ominous Haze Lurks Over The Deadliest Volcano In US, But USGS Says A Repeat Of 1980 Isn’t Coming
  • Hayabusa2’s Target Asteroid Is 4 Times Smaller Than Thought – Can It Still Touch Down On It?
  • In 2011, Slavc The Wolf Journeyed 1,000 Miles To Begin Verona’s First Wolf Pack In 100 Years
  • Anyone Know What These Marine “Y-Larvae” Grow Into? Because Scientists Have No Clue
  • C/2025 A6 (Lemmon) Closest Earth Approach Is Next Month – Will We See It With The Naked Eye?
  • In 2013, A Volcanic Eruption Wiped Out Life On This Remote Island. Then, Somehow, Plants Reemerged
  • 1-Year-Old Orca Takes Out A Big Fat Seal In This Award-Winning – And Extremely Badass – Photo
  • Saturn And Neptune Will Reach Their Brightest In Days – And Look For Saturn’s Temporary Beauty Spot
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version